|
Size: 2851
Comment:
|
Size: 2865
Comment:
|
| Deletions are marked like this. | Additions are marked like this. |
| Line 1: | Line 1: |
| #acl CscGroup:read,write,revert {{attachment:logobiostat.png|OICR_CSC Pathway and Network Analysis Logo Map Logo|align="right"}} <<BR>> |
#acl All:read |
| Line 10: | Line 7: |
| [[ChangjiangXu |ChangJiang Xu]], [[GaryBader | Gary Bader]] | [[ChangjiangXu |Changjiang Xu]], [[GaryBader | Gary Bader]] |
| Line 14: | Line 11: |
| * OICR CSC Projects (PI's name and/or project title listed below) | * OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below) |
| Line 16: | Line 13: |
| * [[CancerStemCellProject/VeroniqueVoisin/Schimmer/AS02 | AS02 (Some points in the reviewed paper to be addressed)]]: [[CancerStemCellProject/ChangjiangXu/AS02 | Association between ClpP expression and known AML mutations]] | * [[CancerStemCellProject/ChangjiangXu/AS02 | AS02 (Some points in the reviewed paper to be addressed): Association between ClpP expression and known AML mutations]] |
| Line 27: | Line 24: |
| * HALT02/JAK2 * [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]] * [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]] |
* John Dick * HALT02/JAK2 1. [[CancerStemCellProject/ChangjiangXu/HALT02_SRC | Differential expression analysis of SRC high vs low (negative) sub-populations]] 1. [[CancerStemCellProject/ChangjiangXu/HALT02_JAK2 | Comparison of the pathways for XG-R/PF-R, XG-NR/PF-NR, and XG-R/PF-NR]] * [[CancerStemCellProject/ChangjiangXu/JD12_relapsedAML | JD12_relapsedAML_Liran: Clustering and pathway analysis of patients with relapsed AML]] |
| Line 35: | Line 34: |
OICR Cancer Stem Cell Program
Experimental Design and Statistical Analysis
- OICR CSC Projects: Biostatistical Part (PI's name and/or project title listed below)
- Aaron Schimmer
- Laurie Ailles
- Peter Dirks
- John Dick
- Bret Pearson